Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
New Microbes New Infect ; 43: 100926, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34367645

RESUMEN

While many patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) eventually produce neutralising antibodies, the degree of susceptibility of previously infected individuals to reinfection by SARS-CoV-2 is currently unknown. To better understand the impact of the immunoglobulin (IgG) level on reinfection in recovered coronavirus disease 2019 (COVID-19) patients, anti-nucleocapsid IgG levels against SARS-CoV-2 were measured in 829 patients with a previously confirmed infection just after their recovery. Notably, 87 of these patients had no detectable IgG concentration. While there was just one case of asymptomatic reinfection 4.5 months after the initial recovery amongst patients with detectable anti-nucleocapsid IgG levels, 25 of the 87 patients negative for anti-nucleocapsid IgG were reinfected within one to three months after their first infection. Therefore, patients who recover from COVID-19 with no detectable anti-nucleocapsid IgG concentration appear to remain more susceptible to reinfection by SARS-CoV-2, with no apparent immunity. Also, although our results suggest the chance is lower, the possibility for recovered patients with positive anti-nucleocapsid IgG findings to be reinfected similarly exists.

2.
Pol J Vet Sci ; 24(1): 51-61, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33847093

RESUMEN

Toxoplasmosis is one of the most important protozoa zoonotic diseases worldwide. The present study describes the clinical, seroprevalence findings with ocular toxoplasmosis and the outcome of medicinal treatment of these cats. This study was carried out on 105 cats with various ocular signs, no historical evidence of ocular trauma or drug/vaccine exposure for at least 3 months prior to admission, and without clinical or laboratory evidence of other systemic diseases. Complete case history, physical and ophthalmic examinations were carried out. The seroprevalence of Toxoplasma gondii antibodies was determined using the Toxoplasma Ab Rapid Test and Enzyme Linked Immunosorbent Assay. Out of 105 examined cats with ocular lesions, 60 cats representing 57.14% were seropositive to T. gondii. Out of these 60 cats, 15 cats (25%) had bilateral ocular abnormalities, 25 cats (41.67%) had right-sided ocular disease, and 20 cats (33.33%) had left-sided ocular disease. There were 38 cats (63.33%) with anterior uveitis, 12 cats (20%) with posterior segment involvement, 5 cats (8.33%) with anterior uveitis and anterior chamber abnormalities, 3 cats (5%) with corneal abnormalities and 2 cats (3.34%) with anterior uveitis with concurrent corneal involvement. There was a significant difference in the index values of IgM and IgG between seropositive and seronegative cats with T. gondii antibodies (p⟨0.05). There was no significant difference between the different ages, genders and breeds of cats with seroprevalence of T. gondii antibodies as well as between the age and total number of cats with seropositive and seronegative T. gondii. Out of 60 treated cats, 28 cats (46.7%), 25 cats (41.7%) and 7 cats (11.6%) showed complete, partial and poor response to treatment, respectively. In conclusion, cats showing ocular signs without obvious etiology should be examined serologically for toxoplasmosis and the seropositive cats should be treated with both specific topical and systemic treatments.


Asunto(s)
Enfermedades de los Gatos/parasitología , Oftalmopatías/veterinaria , Toxoplasmosis Animal/patología , Animales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/tratamiento farmacológico , Gatos , Clindamicina/uso terapéutico , Oftalmopatías/diagnóstico , Oftalmopatías/tratamiento farmacológico , Oftalmopatías/parasitología , Midriáticos/administración & dosificación , Midriáticos/uso terapéutico , Soluciones Oftálmicas , Inhibidores de la Síntesis de la Proteína/uso terapéutico , Combinación Dexametasona y Tobramicina/uso terapéutico , Toxoplasmosis Animal/diagnóstico , Toxoplasmosis Animal/tratamiento farmacológico , Tropicamida/uso terapéutico
3.
Environ Monit Assess ; 190(7): 375, 2018 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-29862438

RESUMEN

Monitoring estuarine ecological-geomorphological dynamics has become a crucial aspect of studying the impacts of climate change and worldwide infrastructure development in coastal zones. Together, these factors have changed the natural eco-geomorphic processes that affect estuarine regimes and comprehensive modelling of coastal resources can assist managers to make appropriate decisions about their sustainable use. This study has utilised Towamba estuary (southeastern NSW, Australia), to demonstrate the value and priority of modelling estuarine dynamism as a measure of the rates and consequences of eco-geomorphic changes. This research employs several geoinformatic modelling approaches over time to investigate and assess how climate change and human activities have altered this estuarine eco-geomorphic setting. Multitemporal trend/change analysis of sediment delivery, shoreline positions and land cover, determined from fieldwork and GIS analysis of remote sensing datasets, shows significant spatio-temporal changes to the elevation and areal extent of sedimentary facies in the Towamba estuary over the past 65 years. Geomorphic growth (~ 2600 m2 annually) has stabilised the estuarine habitats, particularly within native vegetation, salt marsh and mangrove areas. Geomorphic changes have occurred because of a combination of sediment runoff from the mostly unmodified terrestrial catchment, nearshore processes (ocean dynamics) and human activities. The construction of GIS models, verified with water and sediment samples, can characterise physical processes and quantify changes within the estuarine ecosystem. Such robust models will allow resource managers to evaluate the potential effects of changes to the current coastal ecosystems.


Asunto(s)
Monitoreo del Ambiente/métodos , Estuarios , Sistemas de Información Geográfica , Cambio Climático , Conservación de los Recursos Naturales , Ecosistema , Actividades Humanas , Humanos , Nueva Gales del Sur , Análisis Espacio-Temporal , Humedales
4.
Andrologia ; 46(3): 296-307, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23521341

RESUMEN

The present study was conducted to explore the effect of ethyl acetate fraction of hydro-methanolic (40 : 60) extract of seed of Eugenia jambolana on testicular impairment in diabetic rats. In this respect, biomarkers of oxidative stress, genomics and proteomics in testicular tissue were assessed. Side by side, glycated haemoglobin, serum testosterone, activities of glutamate oxaloacetate transaminase and glutamate pyruvate transaminase in serum, epididymal sperm count including reproductive organosomatic indices were evaluated. Results indicate that a significant recovery (P < 0.05) in the levels of these parameters in fraction-treated diabetic group in comparison with diabetic control. A significant recovery was noted (P < 0.05) in the expression of Bax and Bcl-2 gene towards the control after the treatment of said fraction. Histological study also focused a significant recovery (P < 0.05) in the number of different generation of germ cells at stage VII of spermatogenesis in fraction-treated diabetic group. The said fraction treatment to diabetic rat can recover the activities of serum glutamate oxaloacetate transaminase and glutamate pyruvate transaminase significantly towards the control (P < 0.05). Finally, it may be concluded that ethyl acetate fraction of seed of E. jambolana has a promiseable remedial effect on diabetes-induced testicular dysfunctions in male rat without inducing any metabolic toxicity.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/fisiopatología , Fitoterapia , Syzygium , Testículo/efectos de los fármacos , Testículo/fisiopatología , Alanina Transaminasa/sangre , Animales , Apoptosis/efectos de los fármacos , Aspartato Aminotransferasas/sangre , Biomarcadores/metabolismo , Diabetes Mellitus Experimental/genética , Fructosa/metabolismo , Expresión Génica/efectos de los fármacos , Genes bcl-2 , Genómica , Hidroxiesteroide Deshidrogenasas/metabolismo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Proteómica , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas , Ratas Wistar , Vesículas Seminales/efectos de los fármacos , Vesículas Seminales/metabolismo , Epitelio Seminífero/efectos de los fármacos , Epitelio Seminífero/patología , Recuento de Espermatozoides , Testículo/patología , Testosterona/sangre , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
5.
East Mediterr Health J ; 15(1): 122-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19469434

RESUMEN

This indicator-based study assessed the antimalarial drug prescribing and dispensing practices of health care providers in health centres of Khartoum state, and compared these with national guidelines for malaria treatment. A total of 720 patients and their prescriptions in 24 health centres were included. Prescribers adhered to national treatment guidelines for only 278 (38.6%) of patients. Although all were treated for malaria, only 77.6% patients had fever or history of fever and only 64.6% had fever and positive blood films. More than 90% of prescriptions prescribed antimalarial drugs by generic names but dosage forms were correctly written in only 23.5%. There was a high rate of prescribing antimalarial injections. Only half the patients had adequate knowledge of their treatment.


Asunto(s)
Antimaláricos/uso terapéutico , Prescripciones de Medicamentos/estadística & datos numéricos , Adhesión a Directriz/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina/estadística & datos numéricos , Análisis por Conglomerados , Estudios Transversales , Etiquetado de Medicamentos/estadística & datos numéricos , Prescripciones de Medicamentos/normas , Utilización de Medicamentos/estadística & datos numéricos , Fiebre/parasitología , Encuestas de Atención de la Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Malaria/complicaciones , Malaria/diagnóstico , Malaria/tratamiento farmacológico , Malaria/epidemiología , Auditoría Médica , Errores de Medicación/estadística & datos numéricos , Educación del Paciente como Asunto , Pautas de la Práctica en Medicina/normas , Indicadores de Calidad de la Atención de Salud/estadística & datos numéricos , Sudán/epidemiología
6.
Curr Pharm Des ; 14(8): 782-7, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18393879

RESUMEN

Although there are numerous reports of antiarrhythmic use in children, controlled, comparison trials of antiarrhythmic agents in children are virtually nonexistent and most data are obtained from case series of children treated. Effective and safe pharmacological therapy requires that the physicians attempt to identify a drug with the most appropriate profile to attack the most vulnerable parameter of the mechanisms of the cardiac arrhythmia with the least pro arrhythmic/collateral effects. Digoxin in patients with Wolf-Parkinson -White syndrome, verapamil in infants and intravenous quinidine should be avoided as there is clear evidence that they can cause serious side effects. Collateral effects of other antiarrhythmic drugs are discussed in details in this review. Well-designed, controlled trials are needed to further evaluate the comparative efficacy of antiarrhythmics in children, as well as to evaluate dosing and toxicity in various age groups.


Asunto(s)
Antiarrítmicos , Arritmias Cardíacas/tratamiento farmacológico , Antiarrítmicos/efectos adversos , Antiarrítmicos/uso terapéutico , Niño , Contraindicaciones , Interacciones Farmacológicas , Humanos
7.
Am J Cardiol ; 95(5): 607-10, 2005 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-15721100

RESUMEN

Left ventricular inlet/outlet ratio and percent left atrioventricular valve (AVV) guarded by the posterior leaflet are valuable for characterizing atrioventricular septal defect (AVSD). We performed these measurements echocardiographically in normal patients (n = 101), patients who had AVSD (n = 37), those who had isolated perimembranous inlet ventricular septal defect (VSD; n = 12), and those who had "isolated" mitral valve clefts (n = 5). Surgical findings of 38 patients were reviewed. The normal inlet/outlet ratio was 1.03 +/- 0.07. For patients who had AVSD, the ratio was 0.82 +/- 0.06 (95% confidence interval [CI] 0.180 to 0.237, p = 0.001). For patients who had an isolated inlet VSD, this ratio was lower than that in normal patients (0.93 +/- 0.08, 95% CI 034 to 0.116, p = 0.001) but higher than that in patients who had AVSD (95% CI -0.175 to 0.091, p = 0.001). The percent left AVV guarded by the posterior leaflet was 56 +/- 1.4 in normal patients. For patients who had AVSD, it was significantly lower (43 +/- 1.1). For patients who had an isolated VSD and those who had an isolated mitral cleft, it was normal (57 +/- 1.9 and 55 +/- 2.2, respectively). The 2 measurements are valuable in differentiating AVSD from inlet VSD and isolated mitral cleft, but percent left AVV guarded by the posterior leaflet is more specific.


Asunto(s)
Ecocardiografía , Defectos del Tabique Interatrial/diagnóstico por imagen , Defectos del Tabique Interventricular/diagnóstico por imagen , Válvula Mitral/anomalías , Distribución de Chi-Cuadrado , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Válvula Mitral/diagnóstico por imagen , Estudios Retrospectivos , Sensibilidad y Especificidad
8.
Infect Immun ; 63(5): 2062-9, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7729921

RESUMEN

Cellular immune mechanisms resulting in gamma interferon production are critical for protection against visceral leishmaniasis. Antigens stimulating T-cell responses are likely present in the intracellular amastigote form of the parasite, since this is the form found in a mammalian host. To identify T-cell antigens of Leishmania chagasi, the parasite causing South American visceral leishmaniasis, we used a double antibody-T-cell technique to screen an amastigote cDNA library. One cDNA selected (Lcr1) encodes an antigen that stimulated proliferation of splenic T lymphocytes from infected mice that were either resistant (C3H.HeJ) or susceptible (BALB/c) to L. chagasi infection. The Lcr1 cDNA contains four highly divergent 201-bp repeats homologous to the 204-bp repeat of a Trypanosoma cruzi flagellar antigen gene. Results are consistent with a single copy of the Lcr1 gene producing an mRNA of > 10 kb and a protein of > 200 kDa. Recombinant Lcr1, cloned adjacent to polyhistidine and purified on a nickel affinity column, stimulated gamma interferon but not interleukin-4 (IL-4), IL-5, or IL-10 secretion by T-cell-enriched splenocytes from either susceptible or resistant mice during L. chagasi infection. Immunization with Lcr1 partially protected BALB/c mice against challenge with L. chagasi, indicating the utility of the double screening approach in selecting relevant T-cell antigens.


Asunto(s)
Antígenos de Protozoos/inmunología , Inmunidad Celular/inmunología , Inmunización , Leishmania/inmunología , Leishmaniasis Visceral/prevención & control , Proteínas Protozoarias/inmunología , Secuencia de Aminoácidos , Animales , Antígenos de Protozoos/genética , Secuencia de Bases , Northern Blotting , Escherichia coli/genética , Leishmania/genética , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Datos de Secuencia Molecular , Proteínas Recombinantes/inmunología , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Bazo/citología , Bazo/inmunología , Linfocitos T/inmunología
10.
Probl Endokrinol (Mosk) ; 26(4): 42-6, 1980.
Artículo en Ruso | MEDLINE | ID: mdl-6968067

RESUMEN

The effect of 5-oxytryptophan (serotonin metabolic precursor), injected intraperitoneally to female rats (intact and with deafferented mediobasal hypothalamus) on the activity of a number of hypothalamic centres was studied. The activity of cells, both outside and inside the isolated area, proved to alter under the effect of 5-oxytryptophan. The direction of these effects depends on the initial state of the hypothalamic centres and on the hormone in whose presence serotonin acts.


Asunto(s)
5-Hidroxitriptófano/farmacología , Núcleo Celular/ultraestructura , Hipotálamo/ultraestructura , Animales , Núcleo Celular/efectos de los fármacos , Estro , Femenino , Hipotálamo Anterior/ultraestructura , Hipotálamo Medio/ultraestructura , Hipotálamo Posterior/ultraestructura , Cariometría , Embarazo , Ratas
13.
Br J Cancer Suppl ; 3: 46-9, 1978 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-277256

RESUMEN

The effects of oxidants (sensitizers) in the radiolysis of aqueous solutions of pyrimidine and purine bases have been investigated. Their influence on the nature of the permanent radiolysis products and on the kinetics of disappearance of transient intermediates is reported. Particular attention has been paid to the chemical fates of carbocationic intermediates which can be produced from radical-sensitizer interaction.


Asunto(s)
Purinas/efectos de la radiación , Pirimidinas/efectos de la radiación , Fármacos Sensibilizantes a Radiaciones/farmacología , Adenina , Guanosina , Radioquímica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...